wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/bstudior/enableadherence.b1studio.ro/wp-includes/functions.php on line 6114
The COST Action “European Network to Advance Best practices & technoLogy on medication adherencE” (ENABLE) CA19132 aims to create a multidisciplinary network of relevant stakeholders that work collaboratively towards economically viable implementation of medication adherence enhancing technologies across different European healthcare systems.
Due to an ageing society, there is a steady increase in chronic diseases and multi-morbidity in Europe. This requires a multidisciplinary response, which often involves lifestyle changes combined with lifetime medication use.
Technological advances (e.g. smart pillboxes, digital inhalers, tracking devices, e-injection pens, e-Health, big data), have significant potential to support healthcare professionals and empower patients in detecting and managing non-adherence.
What is already known about medication adherence
What is this project focused on delivering to it's public
What is this projects approach to the challenges up ahead
The specific objectives of this Action are:
In the short term impact several important scientific and technological impacts are anticipated due to increased multidisciplinary and private-public collaboration on medication adherence.
ENABLE will tackle a highly relevant issue with substantial cross-sectorial impact. Systematic reviews indicate a wide-ranging negative impact of non-adherence, and reveal consistent associations of nonadherence to worse clinical (i.e. 200,000 deaths) as well as economic outcomes (i.e. €80-125 billion) across the full spectrum of chronic diseases.
Information generated and disseminated through the ENABLE Action will stimulate SMEs and investors even more to develop medical technology (technological impact), being guided by easily accessible local medication adherence expertise centers and a pan-European web platform that help them to reach their end-users and give them a better and more transparent idea of their potential European market share.
As compared to existing efforts outlined above, the ENABLE COST Action will have a unique and specific focus that goes beyond the objectives of the existing efforts. It will be disease and discipline overarching, is multidisciplinary (providers, patients, policy makers), incorporates the latest state-of- the-art adherence enhancing technology through SME involvement and has a strong focus on sustainable, cost-effective implementation across Europe.
